Global $1.25+ Billion Filgrastim Biosimilars Market to 2030: Increase in Patent Expiration, Government Initiatives, Increased Expenditure, Low Cost of Biosimilars, Strong Pipeline of Drugs

Recommended articles

• What is a stock market crash? Understanding its causes and consequences can help investors prepare for a sudden, severe drop in share prices

  A variety of factors and events can cause a stock market crash, an abrupt and unexpected collapse in share prices across the board.

  
• Pomerantz Law Firm Announces the Filing of a Class Action against Voyager Therapeutics, Inc. and Certain Officers – VYGR

  NEW YORK, Jan. 23, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Voyager Therapeutics, Inc. ("Voyager" or the "Company") (NASDAQ: VYGR) and certain of...(read more)

  
• Jericho Expands Energy Portfolio with Agreement for the Acquisition of Hydrogen Technology

  TULSA, Okla. and VANCOUVER, British Columbia, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Jericho Oil Corporation (“Jericho”) (TSX-V: JCO; OTC PINK: JROOF) is pleased to announce that it is has entered into an...(read more)

  
• The University of Arizona Global Campus and MzeroA Announce Partnership

  SAN DIEGO, Jan. 22, 2021 /PRNewswire/ -- The University of Arizona Global Campus (UAGC) has announced a new academic partnership with in-flight training provider MzeroA that will offer students the op...(read more)

  
• ROSEN, LEADING INVESTOR COUNSEL, Files First Securities Class Action Lawsuit Against Lizhi Inc.; Encourages Investors with Losses Exceeding $100K to Contact Firm – LIZI

  NEW YORK, Jan. 22, 2021 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Lizhi Inc. (NASDAQ...(read more)